Cargando…
The FDA’s Experience with Emerging Genomics Technologies—Past, Present, and Future
The rapid advancement of emerging genomics technologies and their application for assessing safety and efficacy of FDA-regulated products require a high standard of reliability and robustness supporting regulatory decision-making in the FDA. To facilitate the regulatory application, the FDA implemen...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973466/ https://www.ncbi.nlm.nih.gov/pubmed/27116022 http://dx.doi.org/10.1208/s12248-016-9917-y |